Arrowhead Research reported $405.3M in Current Assets for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Agios Pharmaceuticals AGIO:US USD 784.94M 85.07M
Alnylam Pharmaceuticals ALNY:US USD 2.69B 219.21M
Anika Therapeutics ANIK:US USD 167.76M 95K
Arrowhead Research ARWR:US USD 405.3M 27.09M
Bluebird Bio BLUE:US USD 160.44M 7.02M
Heron Therapeutics HRTX:US USD 223.8M 29.6M
Intercept Pharmaceuticals ICPT:US USD 545.37M 58.36M
IONIS PHARMACEUT IONS:US USD 2.15B 39.02M
Ligand Pharmaceuticals LGND:US USD 220.43M 23.35M
Mirati Therapeutics MRTX:US USD 1.23B 22.86M
Moderna Inc MRNA:US USD 14.3B 734M
Nektar Therapeutics NKTR:US USD 599.48M 66.05M
Novartis NOVN:VX USD 36.95B 1.19B
Opko Health OPK:US USD 414M 80.75M
Sarepta Therapeutics SRPT:US USD 2.63B 156.63M
Spectrum Pharmaceuticals SPPI:US USD 112.98M 39.4M
Tg Therapeutics TGTX:US USD 182.92M 19.64M
Ultragenyx Pharmaceutical RARE:US USD 1.01B 334.13M
Vertex Pharmaceuticals VRTX:US USD 12.27B 767.5M
Xencor XNCR:US USD 668M 82.06M
YTE INCY:US USD 3.82B 195.27M